What is Blood Glucose: Can it be Measured?

Burrin, Jacky M.; Alberti, K. G. M. M.

doi:10.1111/j.1464-5491.1990.tb01370.x

Cited by 92 publications

(40 citation statements)

References 59 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Plasma blood glucose values tend to be approximately 10% to 18% higher than whole-blood values because of the higher water content of plasma. 21,22 Although a laboratory determination is the most accurate method of measuring the glucose concentration, the results may not be available quickly enough for rapid diagnosis of NH, which thereby delays the initiation of treatment. 23 Bedside reagent test-strip glucose analyzers can be used if the test is performed carefully and the clinician is aware of the limited accuracy of these devices.…”

Section: Laboratory Datamentioning

confidence: 99%

Postnatal Glucose Homeostasis in Late-Preterm and Term Infants

Adamkin¹

2011

Pediatrics

607

278

View full text Add to dashboard Cite

This report provides a practical guide and algorithm for the screening and subsequent management of neonatal hypoglycemia. Current evidence does not support a specific concentration of glucose that can discriminate normal from abnormal or can potentially result in acute or chronic irreversible neurologic damage. Early identification of the at-risk infant and institution of prophylactic measures to prevent neonatal hypoglycemia are recommended as a pragmatic approach despite the absence of a consistent definition of hypoglycemia in the literature.

show abstract

Section: Laboratory Datamentioning

confidence: 99%

Postnatal Glucose Homeostasis in Late-Preterm and Term Infants

Adamkin¹

2011

Pediatrics

607

278

View full text Add to dashboard Cite

show abstract

“…Whole-blood glucose is not stable, and different additives have different effects on the various meters (5,6 ). It therefore is difficult to use a single control material in EQAS for all glucose meters (7 ).…”

mentioning

confidence: 99%

Between-Lot Variation in External Quality Assessment of Glucose: Clinical Importance and Effect on Participant Performance Evaluation

et al. 2005

View full text Add to dashboard Cite

Background: External quality assessment schemes (EQAS) are conducted to evaluate user performance (participant assessment) and to assess different methods and instruments (method assessment). The quality of control materials is crucial to achieving these goals. Inconsistencies in between-lot variations detected by use of different control and sample materials may affect EQAS outcomes. Methods: For the Accu-Chek Sensor, Precision Xtra, Ascensia Elite, and HemoCue 201 glucometers, 3 different lots of glucose strips were used with each instrument. Method assessment results from analysis of capillary blood and 3 control materials were used to calculate between-lot differences. A simulation study was performed to evaluate the effect of between-lot variation on participant assessment results. Results: With the Precision Xtra, the results obtained with EQA control material mirrored those obtained with capillary blood, but for the other instruments, we found between-lot differences of as much as 1.3 mmol/L, which were substantially greater than those found with capillary blood and of clinical importance at decision limits. The simulation study showed an effect on participant assessment results related to the target values, with the percentage of poor results decreasing (38%, 10%, and 4%) with the use of common, method-specific, and lot-specific target values, respectively. Conclusions: Between-lot variation may influence participant EQA results for participant and method assessments. The clinical relevance of between-lot variation

show abstract

“…Venous and capillary samples will give the same result in the fasting state but in the non-fasting state capillary will give results which are approximately 8% higher than venous samples (Burrin and Alberti, 1990). Glucose measured in plasma is approximately 11% higher than glucose measured in whole blood.…”

Section: 2mentioning

confidence: 80%

“…However, what is often assumed to be straightforward is not always the case, as discussed in the review by Burrin and Alberti (1990). Glucose oxidase is the standard laboratory method used to measure glucose in the circulation.…”

Section: 2mentioning

confidence: 99%

See 1 more Smart Citation

Testing for type 2 diabetes in Indigenous Australians: guideline recommendations and current practice

Paul

Ishiguchi

DʼEste

et al. 2017

Medical Journal of Australia

View full text Add to dashboard Cite

Objectives: To determine the proportion of Aboriginal Controlled Community Health Service (ACCHS) patients tested according to three national diabetes testing guidelines; to investigate whether specific patient characteristics were associated with being tested. Design, setting and participants: Cross‐sectional study of 20 978 adult Indigenous Australians not diagnosed with diabetes attending 18 ACCHSs across Australia. De‐identified electronic whole service data for July 2010 – June 2013 were analysed. Main outcomes measures: Proportions of patients appropriately screened for diabetes according to three national guidelines for Indigenous Australians: National Health and Medical Research Council (at least once every 3 years for those aged 35 years or more); Royal Australian College of General Practitioners and Diabetes Australia (at least once every 3 years for those aged 18 years or more); National Aboriginal Community Controlled Health Organisation (annual testing of those aged 18 years or more at high risk of diabetes). Results: 74% (95% CI, 74–75%) of Indigenous adults and 77% (95% CI, 76–78%) of 10 760 patients aged 35 or more had been tested for diabetes at least once in the past 3 years. The proportions of patients tested varied between services (range: all adults, 16–90%; people aged 35 years or more, 23–92%). 18% (95% CI, 18–19%) of patients aged 18 or more were tested for diabetes annually (range, 0.1–43%). Patients were less likely to be tested if they were under 50 years of age, were transient rather than current patients of the ACCHS, or attended the service less frequently. Conclusions: Some services achieved high rates of 3‐yearly testing of Indigenous Australians for diabetes, but recommended rates of annual testing were rarely attained. ACCHSs may need assistance to achieve desirable levels of testing.

show abstract

What is Blood Glucose: Can it be Measured?

Cited by 92 publications

References 59 publications

Postnatal Glucose Homeostasis in Late-Preterm and Term Infants

Postnatal Glucose Homeostasis in Late-Preterm and Term Infants

Between-Lot Variation in External Quality Assessment of Glucose: Clinical Importance and Effect on Participant Performance Evaluation

Testing for type 2 diabetes in Indigenous Australians: guideline recommendations and current practice

Contact Info

Product

Resources

About